GSK on 5 July 2019, opens new state-of-the-art manufacturing facilities in Singapore following an S$130m investment. The...
Nanyang Technological University, Singapore (NTU Singapore) is poised to shape the future of digital health and ...
A new consortium led by the Institute for Health Innovation and Technology (iHealthtech) at NUS will tap on the latest s...
Forward Leading, on 4 July 2019, has announced agenda for the Big Data & AI Leaders’ Summit Singapore 201...
Singapore based medtech startup Advent Access, on 3 July 2019, announced receipt of the CE Mark certificate for its awar...
Researchers from Duke-NUS Medical School, Singapore have uncovered a potential mechanism behind cancer suppression in ba...
A*STAR, Singapore, on 1 July 2019, announced that the National Research Foundation (NRF) has awarded Singapore Immunolog...
NUS Synthetic Biology for Clinical & Technological Innovation (NUS SynCTI) is a focal research programme at the...
In celebration of National Cancer Survivors Day, AstraZeneca, a global, science-led biopharmaceutical company, on 27 Jun...
The Singapore’s drug development efforts have been given additional momentum with the introduction of Experimental...
Doctors may one day be able to diagnose Alzheimer’s disease (AD), the most common cause of severe dementia, and mo...
Thunes (previously TransferTo), a B2B global payments platform for emerging markets, on 25 June 2019, announced KB ...
Gilead Sciences, Inc., on 24 June 2019, announced that the Singapore Health Sciences Authority (HAS) has approved Vosevi...
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...
Novena Global Lifecare, an integrated healthcare platform in over 250 clinics and sales locations and one of the largest...
SingHealth, the largest public healthcare cluster in Singapore, has received a $40 million gift from Ngee Ann...
A new research study by Duke-NUS Medical School, Singapore, on 18 June 2019, describes the process of activation and gen...
A third (34 per cent) of eczema management mobile applications provide information that does not agree with internationa...